On Friday, groups of preschoolers cycled Lake Havasu High School’s hallways for childhood cancer. The event is part of the ...

Positive preliminary outcomes were reported for the first leukemia patient treated with Ossium Health's organ donor bone ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

The bioengineering company Ossium Health has created a new program that offers deep-frozen bone marrow from deceased organ ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Phase II trial of the novel combination, decitabine, venetoclax, and ponatinib achieved bone marrow remission in 80% of ...

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...